Dark

XXII
22nd Century Group Inc.
stock NASDAQ

At Close

May 16, 2025 3:59:30 PM EDT

1.08USD-2.703%(-0.03)88,228

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 16, 2025 9:17:30 AM EDT

1.11USD0.000%(0.00)2,109

After-hours

May 14, 2025 4:18:30 PM EDT

1.13USD-3.291%(-0.04)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 26, 2022

11:00AM EST 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, today announced production of the first cartons of VLN King and VLN Menthol King Cigarettes destined for retail sale as part of the Companys pilot program. GlobeNewswire Inc

Jan 21, 2022

08:00AM EST 22nd Century Group Appoints James A. Mish to Its Board of Directors GlobeNewswire Inc

Jan 18, 2022

08:10AM EST 22nd Century Announces Pilot Launch Of Reduced Nicotine Cigarette To Begin By Mar. 2022 Benzinga

08:00AM EST -- FDA Mandates Addition of Extra Claim Helps You Smoke Less on Packaging -- U.S. Pilot Market Launch with Major Retail Partner by March 2022 GlobeNewswire Inc

Jan 3, 2022

02:24PM EST 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through modern plant science, announced today that Company management will participate in two fireside chat events on Wednesday, January 5. GlobeNewswire Inc

Dec 24, 2021

02:22AM EST The U.S. Food and Drug Administration has authorized the marketing of 22nd Century Group Inc.'s (XXII) VLN King and VLN Menthol King reduced nicotine content cigarettes as modified risk tobacco products, the company said in a statement. RTTNews

Dec 23, 2021

11:00PM EST -- VLN Is Worlds First and Only Combustible Cigarette to Receive FDA MRTP Designation -- FDA Adds Evidence-Based, Headline Claim Helps You Smoke Less to Companys Requested Claims GlobeNewswire Inc

02:32PM EST Mid-Afternoon Market Update: Dow Surges 275 Points; SciPlay Shares Slide Benzinga

12:11PM EST EXCLUSIVE: 22nd Century Group President & COO, Michael Zercher Says Our Plan Is To Launch The Products Into Our Pilot Markets Within 90 Days, Says Next Quarter We Will Launch It Internationally Benzinga

12:11PM EST Mid-Day Market Update: Nasdaq Rises 100 Points; Quidel Shares Plummet Benzinga

12:01PM EST EXCLUSIVE: 22nd Century Group President & COO, Michael Zercher Now Interviewing On Benzinga's Live YouTube TV Benzinga

11:47AM EST 22nd Century Group Issues Press Release Confirming FDA Authorized Marketing Of Co.'s VLN As Modified Risk Tobacco Product Benzinga

11:47AM EST -- VLN Is Worlds First and Only Combustible Cigarette to Receive FDA MRTP Designation -- FDA Adds Evidence-Based, Headline Claim Helps You Smoke Less to Companys Requested Claims -- VLN 95% Reduced Nicotine Content Cigarettes to Launch in the U.S. Within 90 Days -- VLN to Launch Outside the U.S. in First Quarter 2022 GlobeNewswire Inc

11:26AM EST EXCLUSIVE: 22nd Century Group President & COO, Michael Zercher To Appear On Benzinga's Live YouTube TV At 12 p.m. ET On Thursday Benzinga

10:25AM EST UPDATE: 'FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them' -FDA.gov Link To 22nd Century News Benzinga

09:06AM EST FDA Authorized Marketing Of 22nd Century Group Inc's 'VLN King,' 'VLN Menthol King' Combusted, Filtered Cigarettes As Modified Risk Tobacco Products Benzinga

09:05AM EST FDA Authorizes Marketing Of Tobacco Products That Help Reduce Exposure To And Consumption Of Nicotine For Smokers Who Use Them Benzinga

Dec 15, 2021

07:49AM EST Aurora Cannabis, 22nd Century Group To License Biosynthesis Intellectual Property To Cronos Benzinga

Dec 14, 2021

04:10PM EST Aurora Cannabis, 22nd Century Reports 3-Way Non-Exclusive License Deal For Biosynthesis Intellectual Property To Cronos Group, 'intended to assist in the advancement of research and development on the biosynthesis of cannabinoids,' No Terms Disclosed Benzinga

04:06PM EST Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos PR Newswire

Dec 10, 2021

09:21AM EST 22nd Century Ready To Provide Full Commercial Support To New Zealand's Plan To Reduce Nicotine Content Of All Cigarettes Benzinga

09:20AM EST -- New Zealand Ministry of Health announced aggressive measures to reduce smoking, including a reduced nicotine mandate by 2025 GlobeNewswire Inc

Nov 26, 2021

09:25AM EST Cannabis Movers & Shakers: Leafly, Origin Therapeutics, ECGI Holdings, 22nd Century Group Benzinga

Nov 19, 2021

08:31AM EST 22nd Century Reports CFO Jon Franzino Transitions To Chief Admin. Officer, Names Richard Fitzgerald CFO Benzinga

08:30AM EST -- Richard Fitzgerald Joins as Chief Financial Officer -- John Franzino Transitions to Chief Administrative Officer GlobeNewswire Inc

Nov 15, 2021

09:20AM EST -- Califf Is a Longtime Proponent of Tobacco Control; Indicated Nicotine Mandate Should Be Key Priority For FDA -- MRTP Authorization And Launch of VLN Will Serve as Vanguard for FDAs Proposed Nicotine Cap GlobeNewswire Inc

Nov 11, 2021

09:20AM EST 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and improving health and wellness through plant science, today announced that the Company will participate in the following virtual investor conferences during the month of November 2021: GlobeNewswire Inc

Nov 5, 2021

12:07PM EDT Looking Into 22nd Century Group's Return On Capital Employed Benzinga

Nov 4, 2021

01:39PM EDT 22nd Century Group Reports Revenue Gains In Q3, Seeks To Monetize Its Hemp & Cannabis Plant Lines Benzinga

06:09AM EDT 22nd Century Group Q3 EPS $(0.06) Misses $(0.04) Estimate, Sales $7.81M Miss $8.15M Estimate Benzinga

06:00AM EDT 22nd Century Group Reports Business Highlights and Financial GlobeNewswire Inc

05:00AM EDT Earnings Scheduled For November 4, 2021 Benzinga

Oct 20, 2021

09:20AM EDT 22nd Century Group to Host Webcast to Provide Business Update and GlobeNewswire Inc

Oct 13, 2021

04:03PM EDT 22nd Century Group VP Of Regulatory Science To Participate In FDLI Panel In Response To Recent FDA Action On Comprehensive Plan And Reduced Nicotine Mandate Benzinga

04:01PM EDT -- Company Supports This Weeks Positive FDA Action on E-Cigarettes, Demonstrating the Agencys Commitment to Providing Adult Smokers with Alternatives to Highly Addictive Cigarettes -- Applauds FDAs Active Push Forward on Plan to Reduce Amount of Nicotine in All Combustible Cigarettes to Non-Addictive Levels GlobeNewswire Inc

Oct 6, 2021

10:42AM EDT Benzinga Announces The 8 'Rising Star' Companies Being Featured On Its Next 'All Access' Show Benzinga

Oct 1, 2021

09:20AM EDT 22nd Century to Participate in the Benzinga Rising Stars: GlobeNewswire Inc

Sep 27, 2021

04:32PM EDT 22nd Century To Participate In September And October 2021 Investor Conferences; BTIG Cannabis Conference Sept. 29, LD Micro Main Event Conference Oct. 12, Dawson James Sixth Small Cap Growth Stock Conference Oct. 21 Benzinga

04:30PM EDT 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology and intellectual property company focused on improving health and wellness through plant science, today announced that the Company will participate in the following virtual investor conferences during the months of September and October 2021: GlobeNewswire Inc

Sep 7, 2021

11:31AM EDT 22nd Century Group's Return On Capital Employed Insights Benzinga

Aug 30, 2021

03:30PM EDT Why 22nd Century Group Shares Are Trading Lower Today Benzinga

02:35PM EDT Mid-Afternoon Market Update: Affirm Shares Jump Following News Of Amazon Partnership; Adtran Shares Drop Benzinga

12:42PM EDT EXCLUSIVE: James A. Mish, Chief Executive Officer Of 22nd Century Group Says Co Is Focusing On To Diversify Its Business And Grow Geographically Benzinga

12:38PM EDT EXCLUSIVE: James A. Mish, Chief Executive Officer Of 22nd Century Group Says Co Expanded Its Business To Netherlands And Says 'Netherlands Is A Great Opportunity For The Company' Benzinga

12:34PM EDT EXCLUSIVE: James A. Mish, Chief Executive Officer Of 22nd Century Group Now Interviewing On Benzinga's Power Hour Show Benzinga

12:29PM EDT Mid-Day Market Update: Nasdaq Jumps Over 100 Points; Astra Space Shares Plunge Benzinga

10:21AM EDT Mid-Morning Market Update: Markets Mixed; Catalent To Acquire Bettera Benzinga

09:44AM EDT EXCLUSIVE: James A. Mish, Chief Executive Officer Of 22nd Century Group To Appear On Benzinga's Power Hour Show At 12:30 p.m. EDT Benzinga

09:27AM EDT EXCLUSIVE: 22nd Century Group Announces Franchise In Global Specialty Hops Market Benzinga

09:20AM EDT 22nd Century Group Enters Global Specialty Hops Market GlobeNewswire Inc

09:15AM EDT UPDATE: 22nd Century Group CEO Says Co Is 'advancing commercial partnerships rather than competing with global hops producers, beer developers and marketers, flavor and fragrance suppliers, and nutritional/pharmaceutical companies in the hop plant space.' Benzinga

09:15AM EDT 22nd Century Group Announces Franchise In Global Specialty Hops Market Benzinga

09:15AM EDT EXCLUSIVE: 22nd Century Group CEO Issues Letter To Shareholders, Highlights Entry Into Hops Market Benzinga

Aug 26, 2021

12:11PM EDT 22nd Century Group Tweets 'We will formally announce our third franchise on Monday, Aug. 30.' Benzinga

Aug 19, 2021

09:20AM EDT Visionary in theFields of Biotechnology and Genomics to Extend Broad Expertise to Companys Strategy, Technology Development, Commercialization, and Value Creation Efforts GlobeNewswire Inc

Aug 17, 2021

09:20AM EDT 22nd Century Group, Inc. (Nasdaq: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that its Chief Executive Officer, James A. Mish, is scheduled to present at the SNN Network Summer Virtual Event investor conference on Thursday, August 19, 2021 at 2:30 p.m. ET. GlobeNewswire Inc

Aug 16, 2021

09:20AM EDT 22nd Century Group to Ring Nasdaq Closing Bell Today, August 16 GlobeNewswire Inc

Aug 5, 2021

05:43PM EDT 22nd Century Group to Begin Trading on Nasdaq on August 16, 2021 Benzinga

06:39AM EDT 22nd Century Group Q2 EPS $(0.03), Inline Benzinga

06:00AM EDT 22nd Century Group Reports Business Highlights and Financial GlobeNewswire Inc

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Jul 23, 2021

10:24AM EDT Benzinga's Top Ratings Upgrades, Downgrades For July 23, 2021 Benzinga

07:32AM EDT Cowen & Co. Initiates Coverage On 22nd Century Group with Outperform Rating, Announces Price Target of $5 Benzinga

Jul 22, 2021

05:48PM EDT Rhinomed, Alcanna & MariMed Among Top Cannabis Stock Movers On July 22, 2021 Benzinga

09:25AM EDT 22nd Century Reports New Contract Manufacturing Deals, Expands Distribution Network, Manufacturing Capabilities, No Terms Disclosed Benzinga

09:25AM EDT 22nd Century Group Secures New Contract Manufacturing Agreements, GlobeNewswire Inc

Jul 19, 2021

09:25AM EDT 22nd Century Group to Host Webcast to Provide Business Update and GlobeNewswire Inc

Jul 15, 2021

05:33PM EDT World Acceptance, Cresco Labs And TerrAscend Among Top Cannabis Stock Movers On July 15, 2021 Benzinga

Jul 14, 2021

09:25AM EDT 22nd Century Group Adds Strategic Partnerships With Sawatch Agriculture And Folium Botanical For 'Next-Generation Commercial Hemp/Cannabis Plant Breeding and Commercial Scale-Up;' No Terms Disclosed Benzinga

09:25AM EDT 22nd Century Group Adds Strategic Partnerships With Sawatch GlobeNewswire Inc

Jul 7, 2021

05:33PM EDT Sundial Growers, Cresco Labs, RIV Capital Among Top Cannabis Stock Movers On July 7, 2021 Benzinga

Jul 2, 2021

06:18PM EDT Urban-gro, Khiron Life Sciences & CURE Pharmaceutical Among Top Cannabis Stock Movers On July 1, 2021 Benzinga

08:35AM EDT CBD Co. Panacea Life Sciences To Go Public Via Reverse Merger With Hemp Supplier Exactus Benzinga

Jul 1, 2021

05:54PM EDT Sundial, MedMen And GrowGeneration Among Top Cannabis Stock Movers On July 1, 2021 Benzinga

09:17AM EDT 22nd Century Announces Restructuring of Panacea Investment, GlobeNewswire Inc

Jun 25, 2021

09:26AM EDT 22nd Century Group Shareholder Letter From CEO Details Co. Progress Over Last Year, Outlines Future Initiatives Benzinga

09:25AM EDT 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today released an update letter to its shareholders from CEO James A. Mish. GlobeNewswire Inc

Jun 11, 2021

04:51PM EDT The Week In Cannabis: Federal Research Bill, George Lopez, Brazil, Morocco, Columbia Care And More Benzinga

Jun 10, 2021

06:06PM EDT Cannabis Stock Gainers And Losers From June 10, 2021 Benzinga

11:56AM EDT 22nd Century Group Closes Registered Direct Offering, Raises $40M Benzinga

10:22AM EDT 22nd Century 13G Filing From Empery Asset Shows 6.23% Stake In Co. Benzinga

07:00AM EDT Four Cannabis Stocks for the Summer of 2021 GlobeNewswire Inc

Jun 9, 2021

04:30PM EDT 22nd Century Announces Closing of $40 Million Common Stock GlobeNewswire Inc

01:35PM EDT 22nd Century Reports Will Be Added To Russell 2000, 3000, Global Indices, Effective Jun. 28 Benzinga

01:35PM EDT Reduced Nicotine Tobacco and Cannabinoid Innovator 22nd Century GlobeNewswire Inc

Jun 8, 2021

05:07PM EDT Cannabis Stock Gainers And Losers From June 8, 2021 Benzinga

Jun 7, 2021

03:14PM EDT Shares of 22nd Century Group's Cannabis Research Co. Slightly Up On $40M Registered Direct Offering With Cowen and Company Benzinga

10:43AM EDT 22nd Century Group Outlines New Initiatives To Maximize Revenue Opportunities In Hemp/Cannabis Franchise Benzinga

10:42AM EDT -- Close Partnership With Aurora Cannabis Inc. to Enforce Shared Global Biosynthesis IP Rights Against Infringement and Actively Explore Commercial Development Opportunities; Monetization of Key Patented Technology Expected in Second Half of 2021 -- Secures Strategic Partnerships With Two Leading Alkaloid Specialist Plant Breeders to Complete Full Scope of Upstream Capabilities GlobeNewswire Inc

09:25AM EDT 22nd Century Announces $40M Common Stock Registered Direct Offering Of 10M Shares Benzinga

09:25AM EDT 22nd Century Announces $40 Million Common Stock Registered Direct GlobeNewswire Inc

Jun 3, 2021

12:38PM EDT 22nd Century Group: Disrupting The Plant-Based Markets With Improved Genetics Benzinga

10:01AM EDT From BZ Cannabis Capital Conference: 22nd Century Group CEO Says Co Is Developing A 650,000+ SQ. FT. Of Operations Space On 50-Acre Cultivation Site To Meet Existing AZ Demand And New Adult-Use Market Benzinga

10:00AM EDT From BZ Cannabis Capital Conference: 22nd Century Group CEO Says Co Has Very Strong Balance Sheet And It Is Ready To Invest Its Cash To Keep Growing Its Business Benzinga

09:59AM EDT From BZ Cannabis Capital Conference: 22nd Century Group CEO Says Co's Business Model Is To Develop Diverse Plant Strain And Bring Full Commercialization Benzinga

09:56AM EDT From BZ Cannabis Capital Conference: 22nd Century Group CEO Says Co Has Foundational IP In Cannabis Benzinga

May 28, 2021

06:05PM EDT Cannabis Stock Gainers And Losers From May 28, 2021 Benzinga

May 24, 2021

09:06AM EDT 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that the Company will participate in the following virtual investor conferences in May and June 2021: GlobeNewswire Inc

May 19, 2021

05:09PM EDT Cannabis Stock Gainers And Losers From May 19, 2021 Benzinga

May 18, 2021

10:06AM EDT 22nd Century VP of Regulatory Science to Present on Health GlobeNewswire Inc

May 17, 2021

04:57PM EDT Cannabis Stock Gainers And Losers From May 17, 2021 Benzinga

May 10, 2021

12:15PM EDT Mid-Day Market Update: Nasdaq Drops 200 Points; Soliton Shares Spike Higher Benzinga

May 6, 2021

05:18PM EDT Cannabis Stock Gainers And Losers From May 6, 2021 Benzinga

06:06AM EDT 22nd Century Group Q1 EPS $(0.03), Inline, Sales $6.80M Down From $7.10M YoY Benzinga

06:05AM EDT 22nd Century Group Says Believes It Will Be Added To Russell 200, Russell 3000 And Russell Global Benzinga

06:00AM EDT 22nd Century Group Reports Business Highlights and Financial GlobeNewswire Inc

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

May 5, 2021

10:06AM EDT 22nd Century Group Installs State-of-the-Art Nicotine Testing GlobeNewswire Inc

May 4, 2021

09:21AM EDT 22nd Century Group Reports Extension, Expansion Of Plant Research Partnership With KeyGene, No Terms Disclosed Benzinga

09:20AM EDT Updated Agreement Extends Exclusive Program to Create Valuable, New Hemp/Cannabis Varieties and Expands Collaboration to Include 22nd Centurys Two Other Plant Franchises GlobeNewswire Inc

May 3, 2021

05:54PM EDT Cannabis Stock Gainers And Losers From May 3, 2021 Benzinga

01:03PM EDT 'We applaud @RepGwenMoore for petitioning the government to introduce new legislation to reduce the level of nicotine content allowed in any cigarette. We fully support your position and encourage @HHSGov & @FDATobacco to take action' -Tweet Benzinga

Apr 30, 2021

11:06AM EDT 22nd Century Group Says Welcomes Ban On Menthol Cigarettes, Anticipates Further Standards As FDA Commissioner Reports Nicotine Cap On Combustibles 'Still on the Table' Benzinga

11:05AM EDT Applauds Decisive Move and Commitment by FDA to Advance Rule Banning Menthol As First Step to Reduce Addiction, Improve Quitting, Reduce Youth Initiation and Reduced Disparities; Movement on Nicotine Cap by FDA Expected to be Forthcoming GlobeNewswire Inc

Apr 29, 2021

06:21PM EDT Cannabis Stock Gainers And Losers From April 29, 2021 Benzinga

11:38AM EDT Acting FDA Commissioner Woodcock Says Have Not Finished Deliberation On Matter Of Reducing Nicotine Levels In All Cigarettes Benzinga

09:52AM EDT FDA Says Working Toward Issuing Proposed Product Standards Within Next Year TO Ban Menthol As Characterizing Flavor In Cigarettes Benzinga

09:51AM EDT FDA Says Committing To Advancing 2 Tobacco Product Standards To Significantly Reduce Disease And Death From Using Combusted Tobacco Products Benzinga

06:50AM EDT Congresswoman Gwen Moore Adds Voice to Groundswell of Support for GlobeNewswire Inc

Apr 28, 2021

10:28AM EDT 22nd Century Group Option Alert: Jun 18 $3 Calls Sweep (17) near the Ask: 500 @ $2.5 vs 135 OI; Earnings 5/6 Before Open Ref=$5.245 Benzinga

Apr 27, 2021

05:01PM EDT Cannabis Stock Gainers And Losers From April 27, 2021 Benzinga

Apr 26, 2021

10:07AM EDT 22nd Century Group Says Has Fulfilled Order For 3.6M Of Variable Nicotine Content Research Cigarettes For Independent Scientific Studies; Financial Details Not Disclosed Benzinga

10:06AM EDT To Date, 22nd Century Has Provided More Than 31 Million Variable Nicotine ContentResearch Cigarettes for Numerous Independent Scientific Studies GlobeNewswire Inc

Apr 23, 2021

07:26PM EDT Cannabis Stock Gainers And Losers From April 23, 2021 Benzinga

12:11PM EDT 22nd Century Group Option Alert: Jun 18 $4 Calls Sweep (21) near the Ask: 979 @ $1.4 vs 636 OI; Earnings 5/6 Before Open [est] Ref=$4.73 Benzinga

Apr 22, 2021

10:35AM EDT 22nd Century Group to Host Webcast to Discuss First Quarter 2021 GlobeNewswire Inc

Apr 21, 2021

04:57PM EDT Cannabis Stock Gainers And Losers From April 21, 2021 Benzinga

03:34PM EDT Cannabis Stock Gainers And Losers From February 23, 2021 Benzinga

10:36AM EDT 22nd Century Group Issues Annual Letter To Shareholders (Full Letter) Benzinga

10:35AM EDT Companys Confidence in MRTP Authorization is High; Launch of VLN is Only the Beginning for Tobacco Franchise GlobeNewswire Inc

Apr 20, 2021

04:40PM EDT 22nd Century Group Says Fully Prepared To Partner With FDA To Launch Its Vln Reduced Nicotine Content Cigarette Brand Benzinga

04:05PM EDT 22nd Century Announces Co. Is Fully Prepared to Deliver the Solution as Biden Administration Considers Requirement to Lower Nicotine Level for All Cigarettes Sold in U.S. Benzinga

04:01PM EDT 22nd Century Fully Prepared to Deliver the Solution as Biden GlobeNewswire Inc

01:22PM EDT Psaki Says No Nicotine Policy Proposals To Preview Today Benzinga

12:47PM EDT Moody's Says Reduction Of Nicotine Levels In Cigarettes Would Be Challenged By U.S. Tobacco Co.'s In Courts, Would Take Years To Resolve Benzinga

Apr 19, 2021

05:19PM EDT Cannabis Stock Gainers And Losers From April 19, 2021 Benzinga

03:14PM EDT Biden Administration Weighing Nicotine Policy Alongside Ban On Menthol Cigarettes Benzinga

Apr 15, 2021

05:57PM EDT 22nd Century Stands Fully Prepared to Enable New Zealand Proposal GlobeNewswire Inc

Apr 8, 2021

05:08PM EDT Cannabis Stock Gainers And Losers From April 8, 2021 Benzinga

10:07AM EDT 22nd Century Group Regulatory Science VP Joins FDLI Tobacco and Nicotine Products Committee Benzinga

10:06AM EDT 22nd Century Group Regulatory Science VP Joins FDLI Tobacco and GlobeNewswire Inc

Apr 1, 2021

10:08AM EDT 22nd Century Group Says Continues To Be Confident On Renewal Of FDA's Proposed Reduced Nicotine Mandate That Would Make All Cigarettes 'Minimally Or Non-Addictive;' Shares Move Higher Benzinga

10:06AM EDT Multiple Former FDA Commissioners Voice Support for Reduced GlobeNewswire Inc

Mar 19, 2021

01:00PM EDT Becerra Confirmation Boosts 22nd Centurys GlobeNewswire Inc

Mar 12, 2021

10:00AM EST 22nd Century Group Receives Additional $3.7 Million from Cash GlobeNewswire Inc

Mar 11, 2021

07:22AM EST 22nd Century Group Q4 Net Loss $6.4 Mln Or $0.05/Shr RTTNews

07:10AM EST 22nd Century Group, Inc. Common Stock Q4 Sales $7.30M Beat $6.00M Estimate Benzinga

07:00AM EST 22nd Century Group Reports Business Highlights and Financial GlobeNewswire Inc

03:35AM EST Earnings Scheduled For March 11, 2021 Benzinga

Mar 5, 2021

09:15AM EST 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, today announced that members of its management team will participate in three investor conferences during March 2021. GlobeNewswire Inc

Mar 4, 2021

09:15AM EST 22nd Century Group Receives $8.1 Million from Cash Exercise of GlobeNewswire Inc

Mar 3, 2021

09:17AM EST 22nd Century Group Reports Exclusive Deal With CannaMetrix To Accelerate Commercialization Of New Hemp/Cannabis Plant Lines, Intellectual Property, No Terms Disclosed Benzinga

09:00AM EST 22nd Century Group Secures Exclusive Agreement with CannaMetrix to GlobeNewswire Inc

Feb 25, 2021

07:30AM EST 22nd Century Group to Host Webcast to Discuss Fourth Quarter and GlobeNewswire Inc

Feb 24, 2021

10:08AM EST 22nd Century Provides Business Update Letter From CEO RTTNews

10:01AM EST 22nd Century Group CEO Says Believes Co's Current Share Price 'Greatly Undervalues The Untapped Potential Of Our Business And Of Our Extraordinary Potential' Benzinga

10:00AM EST 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, today provided a business update letter from Chief Executive Officer, James A. Mish. GlobeNewswire Inc

Feb 23, 2021

05:44PM EST Cannabis Stock Gainers And Losers From February 23, 2021 Benzinga

Feb 12, 2021

10:28AM EST 22nd Century Group Shares Move Higher; Co Granted U.S. Patent Titled 'TRICHOME SPECIFIC PROMOTERS FOR THE MANIPULATION OF CANNABINOIDS AND OTHER COMPOUNDS IN GRANDULAR TRICHOMES' Benzinga

Feb 10, 2021

10:00AM EST 22nd Century Group and KeyGene Launch Advanced Cannabis Technology GlobeNewswire Inc

Jan 28, 2021

10:00AM EST 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Company is moving its corporate headquarters to the up-and-coming Larkinville District in downtown Buffalo. GlobeNewswire Inc

Jan 26, 2021

12:02PM EST 22nd Century Group Issues Press Release Urging FDA Plan To Proceed With Limiting Of Nicotine Levels In Cigarettes Benzinga

12:00PM EST 22nd Century Group, Inc., a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Buffalo News, the largest newspaper in Western New York, published an op-ed from James A. Mish, 22nd Centurys Chief Executive Officer. GlobeNewswire Inc

Jan 19, 2021

07:34AM EST Federal Court Dismisses Securities Class Action Lawsuit Against 22nd Century Group Benzinga

07:30AM EST Federal Court Dismisses Securities Class Action Lawsuit Against GlobeNewswire Inc

Jan 11, 2021

12:03PM EST 22nd Century Group Prepared To Launch VLK Cigarettes Within 90 Days After Receiving Marketing Authorization From FDA Benzinga

12:00PM EST 22nd Century Group Expands VLN Tobacco Growing Program GlobeNewswire Inc

Dec 17, 2020

10:10AM EST 22nd Century Group Achieves Breakthrough Hemp/Cannabis GMO GlobeNewswire Inc

Dec 8, 2020

10:00AM EST 22nd Century Reports Order For 3.6M New SPECTRUM Variable Nicotine Cigs For US Gov't. Support Research, No Terms Disclosed Benzinga

10:00AM EST 22nd Century Receives Order for 3.6 Million New GlobeNewswire Inc

Dec 4, 2020

10:00AM EST 22nd Century Group to Present at 13th Annual LD Micro Main Event GlobeNewswire Inc

Dec 3, 2020

05:47PM EST Cannabis Stock Gainers And Losers From December 3, 2020 Benzinga

Nov 24, 2020

11:00AM EST 22nd Centurys Vice President of Regulatory GlobeNewswire Inc

Nov 18, 2020

01:19PM EST Yahoo Finance Trending Stocks For Wednesday, Nov. 18, 2020: NKLA, BA, TGT, LOW, PFE, NIO, NAKD, SPCE, RIOT, QCOM, CIIC, KOD, BYND, RIDE, GM, DNK, SCKT, F, JMIA, ROOT, TJX, PCG, IDEX, BABA, MFGP, RIG, XXII, KZIA Benzinga

10:00AM EST 22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston GlobeNewswire Inc

Nov 17, 2020

02:35PM EST 22nd Century Group CEO James Misch Buys 100,000 @ Avg Price: $0.93 Benzinga

Nov 16, 2020

09:45AM EST 22nd Century Group,Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Company will present and meet with investors at the Virtual Fall Investor Summit. The conference is being held virtually November 16 -18, 2020. GlobeNewswire Inc

Nov 5, 2020

07:28AM EST 22nd Century Group Q3 EPS $(0.03) Beats $(0.04) Estimate, Sales $7.30M Beat $5.50M Estimate Benzinga

07:00AM EST 22nd Century Group Reports Financial Results and Business GlobeNewswire Inc

04:34AM EST Earnings Scheduled For November 5, 2020 Benzinga

Oct 22, 2020

10:00AM EDT 22nd Century Group to Host Third Quarter 2020 Webcast and Conduct GlobeNewswire Inc

Oct 19, 2020

10:01AM EDT 22nd Century Group To Highlight Reduced Nicotine Technology At Food And Drug Law Institute's Tobacco And Nicotine Products Regulation And Policy Conference Oct. 21 At 11:15 a.m. EDT Benzinga

10:00AM EDT 22nd Century Group to Highlight its Reduced Nicotine Technology at GlobeNewswire Inc

Oct 14, 2020

01:02PM EDT UPDATE: 22nd Century Group Reports New Patent Provides Co. With 'rapid pathway to introduce very low nicotine traits into virtually any variety of tobacco, including bright, burley, oriental, and cigar tobacco varieties' Benzinga

01:01PM EDT 22nd Century Group Granted New Patent For Reducing Nicotine In Tobacco Plants Benzinga

01:00PM EDT 22nd Century Group Achieves Breakthrough Technology; Granted New GlobeNewswire Inc

Sep 24, 2020

04:07PM EDT 22nd Century CEO Sends Letter To Shareholders Benzinga

04:05PM EDT 22nd Century Group, Inc. (NYSE American: XXII) (22nd Century or the Company), a leading plant-based, life science company driven by next generation biotechnology, today provided a strategy update letter from Chief Executive Officer, James A. Mish. GlobeNewswire Inc

Sep 18, 2020

06:21AM EDT 'China's vaping giant Relx gears up for US entry' -Tech Crunch Benzinga

Sep 17, 2020

04:05PM EDT 22nd Century Appoints Leading Plant Biotechnology Expert Dr. GlobeNewswire Inc

Aug 27, 2020

11:30AM EDT 22nd Century Group to Present at the LD Micro 500 Virtual Conference GlobeNewswire Inc

Aug 6, 2020

09:13AM EDT 22nd Century Group Q2 EPS $(0.04), Inline, Sales $6.40M Beat $5.00M Estimate Benzinga

07:01AM EDT 22nd Century Group Reports Financial Results and Business GlobeNewswire Inc